- Home
- CTMX vs ABSI Comparison
CTMX vs ABSI Comparison
Compare CTMX & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- ABSI
- Stock Information
- Founded
- CTMX 2008
- ABSI 2011
- Country
- CTMX United States
- ABSI United States
- Employees
- CTMX N/A
- ABSI N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- CTMX Health Care
- ABSI Health Care
- Exchange
- CTMX Nasdaq
- ABSI Nasdaq
- Market Cap
- CTMX 378.1M
- ABSI 347.0M
- IPO Year
- CTMX 2015
- ABSI 2021
- Fundamental
- Price
- CTMX $2.64
- ABSI $3.03
- Analyst Decision
- CTMX Strong Buy
- ABSI Strong Buy
- Analyst Count
- CTMX 2
- ABSI 5
- Target Price
- CTMX $5.00
- ABSI $8.40
- AVG Volume (30 Days)
- CTMX 11.3M
- ABSI 3.0M
- Earning Date
- CTMX 05-12-2025
- ABSI 05-13-2025
- Dividend Yield
- CTMX N/A
- ABSI N/A
- EPS Growth
- CTMX 128.27
- ABSI N/A
- EPS
- CTMX 0.49
- ABSI N/A
- Revenue
- CTMX $147,557,000.00
- ABSI $4,815,000.00
- Revenue This Year
- CTMX N/A
- ABSI $151.99
- Revenue Next Year
- CTMX N/A
- ABSI $179.72
- P/E Ratio
- CTMX $5.44
- ABSI N/A
- Revenue Growth
- CTMX 23.81
- ABSI N/A
- 52 Week Low
- CTMX $0.40
- ABSI $2.01
- 52 Week High
- CTMX $2.82
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- CTMX 67.47
- ABSI 60.11
- Support Level
- CTMX $2.35
- ABSI $2.59
- Resistance Level
- CTMX $2.75
- ABSI $2.95
- Average True Range (ATR)
- CTMX 0.25
- ABSI 0.15
- MACD
- CTMX -0.01
- ABSI 0.03
- Stochastic Oscillator
- CTMX 78.82
- ABSI 92.16
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.